Overview

Mitotane (Lysodren) 500 mg tablets serve an exceptionally narrow indication, adrenal cortical carcinoma, which makes sourcing strategy rather than mechanism the central concern for B2B buyers. Because the patient population is small and the product is specialist-managed, supply continuity, authenticated origin and controlled logistics decide whether therapy can be sustained. Procurement discipline and dependable logistics are the deciding factors that keep this rare-disease therapy continuously available.

How It Works

Mitotane is an adrenolytic agent derived from the dichlorodiphenyltrichloroethane class that selectively accumulates in adrenal cortical tissue. It suppresses steroid synthesis and exerts a cytotoxic effect on adrenocortical cells, reducing cortisol production in tumors of the adrenal cortex. Although the pharmacological basis is established, the commercial reality is a low-volume, high-criticality product whose availability directly affects a vulnerable patient group, so buying discipline outweighs novelty in importance.

Indications

Mitotane is indicated for the treatment of adrenocortical carcinoma, often used adjuvantly after surgery or for advanced disease. Its use is confined to this rare endocrine malignancy and is managed by specialist centers. Procurement teams should expect infrequent but essential orders and should maintain reliable sourcing relationships, because interruptions in a rare-disease therapy are difficult to backfill quickly.

Dosage & Administration

The product is supplied as 500 mg tablets, 100 tablets per box, taken orally in divided doses with food to improve tolerability. Dosing is highly individualized and monitored through plasma levels. Buyers should verify the 500 mg strength and the 100-tablet count, because mitotane requires long-term, dose-titrated use that depends on receiving the correct high-strength presentation.

Storage & Sourcing

Store below 30 °C in the original container, protected from moisture and light. As a rare-disease, specialist product, mitotane should be sourced from licensed manufacturers such as Tlph or BMS with full GMP documentation. Buyers should request certificates of analysis, confirm batch traceability and secure dependable lead times, because the small patient pool cannot absorb supply gaps.

FAQ

Q: Why is mitotane sourcing more critical than for common oncology drugs? The indication is rare and the patient pool small, so stockouts are hard to backfill and directly threaten continuous therapy for a vulnerable group.

Q: What logistics details should buyers confirm? Verify GMP and analysis certificates, batch traceability and dependable lead times from authorized manufacturers before distribution.

Q: Does the high strength affect procurement? Yes. The 500 mg presentation supports dose-titrated, long-term use, so accurate strength and 100-tablet count are essential to avoid interruptions.